#Tobacco Market Forecast

[amr-jayprakash]

The global tobacco market was valued at $183.1 billion in 2019 and is estimated to reach $262.8 billion by 2027, registering a CAGR of 6.7% from 2021 to 2027. Tobacco is a common name for the plant Nicotiana tabacum and, to a lesser extent, Aztec tobacco (Nicotiana Rustica). 

[themarketinsights]

Smokeless Tobacco Market to Enjoy ‘Explosive Growth’ to 2028 | Imperial Tobacco Group, Altria Group, Universal, Japan Tobacco

Advance Market Analytics published a new research publication on “Global Smokeless Tobacco Market Insights, to 2028” with 232 pages and enriched with self-explained Tables and charts in presentable format. In the study, you will find new evolving Trends, Drivers, Restraints, Opportunities generated by targeting market-associated stakeholders. The growth of the Smokeless Tobacco market was mainly driven by the increasing R&D spending across the world.

Major players profiled in the study are:

Altria Group (United States), British American Tobacco (United Kingdom), Imperial Tobacco Group (United Kingdom), Universal Corporation (United States), Reynolds Tobacco Company (United States), The Mac Baren Tobacco Company (Denmark), Japan Tobacco Inc (Japan), Swedish Match (Sweden), Philip Morris Products S.A (Switzerland)

Get Free Exclusive PDF Sample Copy of This Research @ https://www.advancemarketanalytics.com/sample-report/13309-global-smokeless-tobacco-market#utm_source=DigitalJournalVinay

Scope of the Report of Smokeless Tobacco

Smokeless tobacco, one of the oldest forms of tobacco in the world. It is consumed through orally or nasally includes chewing, sucking or sniffing and delivers nicotine without combustion. There are many different forms of smokeless tobacco products consumed globally. Increasing consumption of smokeless tobacco among the millennial population in various developing nations especially in India and Bangladesh which is influencing sales of smokeless tobacco in Asia-Pacific region.

In January 2019, Japan Tobacco Inc. launched Ploom TECH which is a low temperature tobacco vapor product, and Ploom S, a high temperature tobacco vapor product, in its online store and Ploom shops across Japan.

In June 2018, America Cancer Society has removed smokeless tobacco from list of 17 risk factors for cancer, a tacit acknowledgement that the risk of cancer from smokeless tobacco is minimum.

The Global Smokeless Tobacco Market segments and Market Data Break Down are illuminated below:

by Type (Snuff Tobacco, Dipping Tobacco, Chewing Tobacco, Others Smokeless Tobacco), Application (Oral, Nasal), Form Type (Dry, Moist)

Market Opportunities:

Numerous Countries Governments have Increased the Excise Duty on Cigarettes

Increasing Consumption of Chewing Tobacco in Emerging Countries

Market Drivers:

Increasing instances of Ban on Smoking in Public Places Across the World

Surging Price of Cigarettes Due to Which the Average Smokers Cannot Able to Buy Cigarettes on a Regular Basis

Market Trend:

Continuously New Product Launches By Companies

What can be explored with the Smokeless Tobacco Market Study?

Gain Market Understanding

Identify Growth Opportunities

Analyze and Measure the Global Smokeless Tobacco Market by Identifying Investment across various Industry Verticals

Understand the Trends that will drive Future Changes in Smokeless Tobacco

Understand the Competitive Scenarios

Track Right Markets

Identify the Right Verticals

Region Included are: North America, Europe, Asia Pacific, Oceania, South America, Middle East & Africa

[shubhamimarc]

Philippines E-Cigarette Market Demand, Trends and Opportunity 2024-2032

Philippines E-Cigarette Market Overview

Base Year: 2023

Historical Years: 2018-2023

Forecast Years: 2024-2032

Market Growth Rate: 16.70% (2024-2032)

The Philippines E-Cigarette Market is driven by increasing health consciousness among smokers and the growing popularity of vaping as a smoking alternative. According to the latest report by IMARC Group, The Philippines e-cigarette market is projected to exhibit a growth rate (CAGR) of 16.70% during 2024-2032.

Download a sample copy of the Report: https://www.imarcgroup.com/philippines-e-cigarette-market/requestsample

Philippines E-Cigarette Market Trends and Drivers:

The Philippines e-cigarette market is expanding rapidly, owing to several interconnected factors. Primarily, the market is driven by the growing number of smokers looking for healthier alternatives to regular cigarettes. Besides this, there is a trend for vaping products because of rising health consciousness and knowledge of the negative impacts of smoking. Moreover, the introduction of diverse e-cigarette products with varying flavors and nicotine levels is attracting a broad consumer base, including younger adults. In line with these factors, the efforts of the government bodies to regulate and formalize the e-cigarette industry through policies such as taxation and quality standards are contributing to the expansion of the Philippines e-cigarette market by fostering a safer and highly structured market environment. Additionally, the growing acceptance of e-cigarettes as a smoking cessation tool is further propelling demand.

Key trends in the Philippines e-cigarette market include the development of advanced vaping devices such as pod systems and disposable e-cigarettes, which offer convenience and ease of use. Furthermore, manufacturers are investing in innovative technologies to enhance the user experience, like longer battery life, improved e-liquid capacity, and customizable features. Another trend is the rising focus on sustainability, with brands offering recyclable and eco-friendly products to appeal to environmentally conscious consumers. Apart from this, the growth of online retail and dedicated vape shops is making e-cigarettes more accessible across the country. Consequently, these trends, along with increasing collaborations between local and international brands to introduce new products, are anticipated to drive the Philippines e-cigarette market in the coming years.

IMARCs report provides a deep dive into the market analysis, outlining the current trends, underlying Philippines e-cigarette market demand, and growth trajectories.

Philippines E-Cigarette Industry Segmentation:

The report has segmented the market into the following categories:

Product Insights:

Modular E-Cigarette 

Rechargeable E-Cigarette

Next-Generation E-Cigarette

Disposable E-Cigarette

Flavor Insights:

Tobacco

Botanical

Fruit

Sweet

Beverage

Others

Mode of Operation Insights:

Automatic E-Cigarette

Manual E-Cigarette

Distribution Channel Insights:

Specialty E-Cig Shops

Online

Supermarkets and Hypermarkets

Tobacconist

Others

Regional Insights: 

Luzon

Visayas

Mindanao

Competitive Landscape:

The market research report has also provided a comprehensive analysis of the competitive landscape. Competitive analysis such as market structure, key player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided.

Key highlights of the Report:

Market Performance (2018-2023)

Market Outlook (2024-2032)

COVID-19 Impact on the Market

Porter’s Five Forces Analysis

Strategic Recommendations

Historical, Current and Future Market Trends

Market Drivers and Success Factors

SWOT Analysis

Structure of the Market

Value Chain Analysis

Comprehensive Mapping of the Competitive Landscape

Note: If you need specific information that is not currently within the scope of the report, we can provide it to you as a part of the customization.

About Us:

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Contact Us:

IMARC Group

134 N 4th St. Brooklyn, NY 11249, USA

Email: sales@imarcgroup.com

Tel No:(D) +91 120 433 0800

United States: +1-631-791-1145

[head-post]

UK inflation surges to 2.3%

UK inflation jumped above the Bank of England’s 2% target, with core price growth accelerating as well, according to Reuters.

Consumer prices rose 2.3% in October, helped by an increase in domestic energy tariffs after rising 1.7% in September. The latest BoE forecast and a Reuters poll of economists pointed to a weaker Consumer Price Index (CPI) at 2.2%.

Meanwhile, sterling strengthened by almost a third of a cent against the US dollar following the data release before giving back most of that gain. Interest rate futures priced in a slightly slower pace of rate cuts, with bond prices falling.

The rise lifted inflation to a six-month high and was the biggest monthly increase in annual CPI since inflation peaked in October 2022. Service price inflation, which the BoE saw as a key indicator of domestic price pressures, rose to 5.0% in October from 4.9% in September, the Office for National Statistics said.

However, core inflation, which excludes energy, food, alcohol and tobacco prices, rose to 3.3% from September’s 3.2%, missing market expectations. The BoE also said this month it expected overall inflation to rise to 2.4% and 2.5% in November and December.

The Bank said the first budget of the new UK government would likely boost inflation next year. Moreover, US President-elect Donald Trump’s threat to impose high import duties is adding uncertainty to the economic outlook.

Prime Minister Keir Starmer’s new government pledged to boost UK economic growth but was criticised by employers over the higher employment taxes they would have to pay from April next year. There is also upward pressure on prices from the labour market, where many employers are facing a shortage of candidates.

Meanwhile, yields on two-year UK government bonds, which are sensitive to interest rate speculation, rose about 4 basis points.

Read more HERE

[health-views-updates]

2024-2032 Nebulizer Market Outlook: Revenue, Trends, and Growth

The global Nebulizer Market Revenue is projected to witness substantial growth in the coming years, driven by increasing respiratory health concerns, rising incidences of chronic pulmonary diseases, and advancements in nebulization technology. The market, valued at USD 1.45 billion in 2022, is expected to expand significantly by 2030, registering a compound annual growth rate (CAGR) of 6.23% during the forecast period.

Nebulizers play a crucial role in the administration of medication directly into the lungs, making them indispensable in managing respiratory diseases such as asthma, chronic obstructive pulmonary disease (COPD), and bronchitis. The market’s growth trajectory is further bolstered by increasing air pollution levels, rising tobacco consumption, and a growing aging population vulnerable to respiratory ailments.

Technological innovations, including portable and user-friendly nebulizers, have enhanced patient compliance and convenience, broadening the market’s consumer base. Moreover, the COVID-19 pandemic underscored the importance of respiratory health, further driving the demand for nebulizers worldwide.

Get Free Sample Report @ https://www.snsinsider.com/sample-request/2982

Market Dynamics and Key Trends

The nebulizer market is undergoing a transformative phase with several key trends shaping its future:

Portability and Compact Designs: The development of lightweight and battery-operated nebulizers has made respiratory treatments accessible anytime and anywhere.

Technological Advancements: Integration of Bluetooth technology and smart connectivity in nebulizers allows real-time monitoring of patient data, enhancing treatment efficiency.

Rising Awareness Campaigns: Increasing public awareness about respiratory health and the benefits of early diagnosis are propelling market growth.

Growth in Home Healthcare: The shift towards home-based care, driven by the rising costs of hospitalization, has significantly boosted the adoption of nebulizers.

Regional Insights

North America currently dominates the nebulizer market, attributed to its advanced healthcare infrastructure, high prevalence of respiratory disorders, and increased healthcare expenditure. Meanwhile, Asia-Pacific is emerging as a lucrative market due to a growing population, urbanization, and improved healthcare access.

Industry Challenges

Despite the promising growth, the market faces challenges such as high costs of advanced nebulizers, lack of awareness in developing regions, and limited availability of skilled healthcare professionals for effective usage and maintenance of devices.

Competitive Landscape

The nebulizer market is highly competitive, with key players focusing on research and development to introduce innovative products. Partnerships, acquisitions, and expansions are common strategies adopted to strengthen market positions and meet the increasing demand.

About Us SNS Insider is one of the leading market research and consulting agencies that dominates the market research industry globally. Our company's aim is to give clients the knowledge they require in order to function in changing circumstances. In order to give you current, accurate market data, consumer insights, and opinions so that you can make decisions with confidence, we employ a variety of techniques, including surveys, video talks, and focus groups around the world.

Contact Us Akash Anand – Head of Business Development & Strategy Email: info@snsinsider.com Phone: +1-415-230-0044 (US) | +91-7798602273 (IND)

[jayanthitbrc]

Digital Dentistry Market Competitors and Strategies: Trends Driving Innovation

The digital dentistry global market report 2024from The Business Research Company provides comprehensive market statistics, including global market size, regional shares, competitor market share, detailed segments, trends, and opportunities. This report offers an in-depth analysis of current and future industry scenarios, delivering a complete perspective for thriving in the industrial automation software market.

Digital Dentistry Market, 2024report by The Business Research Company offers comprehensive insights into the current state of the market and highlights future growth opportunities.

Market Size - The digital dentistry market size has grown rapidly in recent years. It will grow from $5.50 billion in 2023 to $6.14 billion in 2024 at a compound annual growth rate (CAGR) of 11.5%. The growth in the historic period can be attributed to the proliferation of private dental clinics and chains, increasing dental disorders, demand for aesthetic dentistry, and increasing geriatric population demanding more dental care.

The digital dentistry market size is expected to see rapid growth in the next few years. It will grow to $9.54 billion in 2028 at a compound annual growth rate (CAGR) of 11.7%. The growth in the forecast period can be attributed to greater awareness of oral health and the benefits of digital dentistry, expanding dental tourism, integration of tele-dentistry, enhanced patient experience, and comfort with digital solutions. Major trends in the forecast period include the adoption of artificial intelligence, the growth of teledentistry services, the expansion of 3D printing applications, the integration of augmented reality, advancements in intraoral scanners, the embrace of blockchain technology, and the development of smart dental implants.

Order your report now for swift delivery @ https://www.thebusinessresearchcompany.com/report/digital-dentistry-global-market-report

Scope Of Digital Dentistry MarketThe Business Research Company's reports encompass a wide range of information, including:

1. Market Size (Historic and Forecast): Analysis of the market's historical performance and projections for future growth.

2. Drivers: Examination of the key factors propelling market growth.

3. Trends: Identification of emerging trends and patterns shaping the market landscape.

4. Key Segments: Breakdown of the market into its primary segments and their respective performance.

5. Focus Regions and Geographies: Insight into the most critical regions and geographical areas influencing the market.

6. Macro Economic Factors: Assessment of broader economic elements impacting the market.

Digital Dentistry Market Overview

Market Drivers -The increasing prevalence of dental disorders is expected to propel the growth of the digital dentistry market going forward. Dental disorders refer to a range of conditions affecting the teeth, gums, and oral structures, including cavities, gum disease, tooth decay, and oral infections. The dental disorders are caused due to factors such as poor oral hygiene practices, unhealthy dietary habits, tobacco use, inadequate access to dental care, and aging populations. Digital dentistry is transforming the diagnosis and treatment of dental disorders with technologies such as computer-aided design or computer-aided manufacturing (CAD or CAM) systems, digital imaging, and artificial intelligence (AI) diagnostics, enhancing precision and outcomes. For instance, in August 2022, according to the National Health Service (NHS), a UK-based healthcare system, in the business year 2021–22, there was a notable surge of 120.0% in the delivery of dental treatments, totaling 26.4 million courses compared to the previous year. Therefore, the increasing prevalence of dental disorders is driving the growth of the digital dentistry market.

Market Trends - Major companies operating in the digital dentistry market are focusing on the integration of artificial intelligence and machine learning technologies into diagnosis products, such as AI-guided orthodontic scans, to enhance treatment precision, efficiency, and early detection capabilities. An AI-guided orthodontics scan uses artificial intelligence to assist in conducting precise scans of a patient's teeth, aiding in treatment planning and customization. For instance, in June 2023, DentalMonitoring, a France-based medical equipment manufacturing company, launched an AI-guided scan for orthodontics, named ScanAssist. The device utilizes AI-guided instructions and real-time feedback to assist patients in completing their scans, aiming to enhance patient engagement and experience. The in-app system generates a 3D mouth model that tracks patients' scans, offering high-quality images and detailed analysis of treatment progress and oral health. ScanAssist, a recent feature of the DentalMonitoring app, employs software and AI to identify over 130 intraoral observations for braces and aligner treatments.

The digital dentistry market covered in this report is segmented –

1) By Type: Instruments, Consumables 2) By Specialty Areas: Orthodontics, Prosthodontics, Implantology, Other Speciality Areas 3) By Application: Diagnostics, Therapeutics, Other Applications 4) By End User: Hospitals, Dental Clinics, Others End Users

Get an inside scoop of the digital dentistry market, Request now for Sample Report @ https://www.thebusinessresearchcompany.com/sample.aspx?id=15789&type=smp

Regional Insights - North America was the largest region in the digital dentistry market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the digital dentistry market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

Key Companies - Major companies operating in the digital dentistry market are 3M Company, Danaher Corporation, Henry Schein Inc., Zimmer Biomet Holdings Inc., Patterson Companies Inc., DWS Systems, Dentsply sirona Inc., Align Technology Inc., Institut Straumann AG., Planmeca Oy, Carestream Health Inc., Glidewell Dental, Benco Dental, Ivoclar Vivadent, ZimVie Inc, Midmark Corporation, Stratasys, J. Morita Corporation, 3Shape A/S, Roland DG Corporation, Formlabs Inc., KaVo Dental GmbH, Implant Sciences Corporation, Biolase Inc, VITA North America, Medit, exocad GmbH, Kuraray Noritake Dental Inc, DOT GmBH, Apteryx Inc

Table of Contents 1. Executive Summary 2. Digital Dentistry Market Report Structure 3. Digital Dentistry Market Trends And Strategies 4. Digital Dentistry Market – Macro Economic Scenario5. Digital Dentistry Market Size And Growth ….. 27. Digital Dentistry Market Competitor Landscape And Company Profiles28. Key Mergers And Acquisitions 29. Future Outlook and Potential Analysis 30. Appendix

Contact Us: The Business Research Company Europe: +44 207 1930 708 Asia: +91 88972 63534 Americas: +1 315 623 0293 Email: info@tbrc.info

Follow Us On: LinkedIn: https://in.linkedin.com/company/the-business-research-company Twitter: https://twitter.com/tbrc_info Facebook: https://www.facebook.com/TheBusinessResearchCompany YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ Blog: https://blog.tbrc.info/ Healthcare Blog: https://healthcareresearchreports.com/ Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

[amrutatbrc1]

Apixaban Market : Technology Advancements, Industry Insights, Trends And Forecast 2033

The apixaban global market report 2024 from The Business Research Company provides comprehensive market statistics, including global market size, regional shares, competitor market share, detailed segments, trends, and opportunities. This report offers an in-depth analysis of current and future industry scenarios, delivering a complete perspective for thriving in the industrial automation software market.

Apixaban Market, 2024 report by The Business Research Company offers comprehensive insights into the current state of the market and highlights future growth opportunities.

Market Size - The apixaban market size has grown strongly in recent years. It will grow from $2.69 billion in 2023 to $2.92 billion in 2024 at a compound annual growth rate (CAGR) of 8.7%.  The growth in the historic period can be attributed to increased incidence of atrial fibrillation, aging population, regulatory approvals and expansions, favorable clinical outcomes, and shift from warfarin to NOACs.

The apixaban market size is expected to see strong growth in the next few years. It will grow to $4.12 billion in 2028 at a compound annual growth rate (CAGR) of 9.0%.  The growth in the forecast period can be attributed to continued incidence of cardiovascular diseases, increasing awareness and diagnosis rates, expansion in emerging markets, aging global population, health policy and reimbursement changes. Major trends in the forecast period include advancements in drug delivery systems, increasing research and developments, innovation and collaborations, approval of apixaban by the FDA, digital health and telemedicine.

Order your report now for swift delivery @ https://www.thebusinessresearchcompany.com/report/apixaban-global-market-report

The Business Research Company's reports encompass a wide range of information, including:

1. Market Size (Historic and Forecast): Analysis of the market's historical performance and projections for future growth.

2. Drivers: Examination of the key factors propelling market growth.

3. Trends: Identification of emerging trends and patterns shaping the market landscape.

4. Key Segments: Breakdown of the market into its primary segments and their respective performance.

5. Focus Regions and Geographies: Insight into the most critical regions and geographical areas influencing the market.

6. Macro Economic Factors: Assessment of broader economic elements impacting the market.

Market Drivers - The rising prevalence of cardiovascular disease is expected to propel the growth of the apixaban market going forward. Cardiovascular disease encompasses a range of conditions affecting the heart and blood vessels, including coronary artery disease, stroke, and heart failure. The rising prevalence of cardiovascular disease is due to sedentary lifestyles, poor dietary habits, tobacco use, obesity, high blood pressure, diabetes, and aging populations. Apixaban is utilized in the management of cardiovascular disease by reducing the risk of blood clots by preventing conditions such as stroke, deep vein thrombosis, and pulmonary embolism. For instance, in January 2024, according to the American Heart Association, a US-based nonprofit organization, the number of deaths caused by cardiovascular diseases reached 931,578, an uptick of fewer than 3,000 fatalities compared to the 928,741 in 2023. Therefore, the rising prevalence of cardiovascular disease drives the growth of the apixaban market.

Market Trends - Major companies operating in the apixaban market are focusing on developing innovative products, such as generic anticoagulant medicine, to increase affordability and accessibility for patients while also expanding their market reach and competitiveness. A generic anticoagulant medicine is a drug that prevents blood clot formation by inhibiting various factors in the coagulation process, reducing the risk of stroke and other cardiovascular events. For instance, in October 2022, Tiefenbacher Pharmaceuticals, a Germany-based healthcare company, launched a generic version of Apixaban in Canada. This oral anticoagulant is used for prophylaxis post-elective hip or knee replacement, stroke prevention in atrial fibrillation, and treatment of deep vein thrombosis and pulmonary embolism, catering to a broad spectrum of thrombotic disorders. The company has developed 2.5 mg and 5 mg anticoagulant tablets in their Indian laboratories, to be distributed in Canada through a partnership with generic pharmaceutical companies, followed by a subsequent launch in additional global markets. This strategic move facilitates significant cost savings for international healthcare systems and enhances accessibility to life-improving treatments for millions of patients.

The apixaban market covered in this report is segmented –

1) By Dosage Form: Capsule, Tablets 2) By Application: Deep Vein Thrombosis (DVT), Pulmonary Embolism (PE) 3) By End-Users: Hospitals, Homecare, Specialty Clinics, Other End-Users

Get an inside scoop of the apixaban market, Request now for Sample Report @ https://www.thebusinessresearchcompany.com/sample.aspx?id=15979&type=smp

Regional Insights - North America was the largest region in the apixaban market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the apixaban market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Key Companies - Major companies operating in the apixaban market are  Pfizer Inc., Johnson & Johnson, F. Hoffmann-La Roche Ltd, Merck & Co. Inc., Sanofi S.A., Bristol-Myers Squibb Company, Eli Lilly and Company, Amgen Inc., Viatris Inc., Teva Pharmaceutical Industries Ltd., Sandoz Group AG, Daiichi Sankyo Company Limited, Fresenius Kabi AG, Hetero Drugs Ltd, Eisai Co. Ltd, Sun Pharmaceutical Industries Ltd., Aurobindo Pharma Limited, Dr. Reddy's Laboratories Ltd., Cipla Limited, Aspen Pharmacare Holdings Limited, Lupin Limited, Glenmark Pharmaceuticals Ltd., Torrent Pharmaceuticals Ltd, Medichem S.A., Centaur Pharmaceuticals Pvt. Ltd., Simson Pharma Limited, OPOCRIN SPA, Pinnacle Life Sciences Private Limited

Table of Contents 1. Executive Summary 2. Apixaban Market Report Structure 3. Apixaban Market Trends And Strategies 4. Apixaban Market – Macro Economic Scenario 5. Apixaban Market Size And Growth ….. 27. Apixaban Market Competitor Landscape And Company Profiles 28. Key Mergers And Acquisitions 29. Future Outlook and Potential Analysis 30. Appendix

Contact Us: The Business Research Company Europe: +44 207 1930 708 Asia: +91 88972 63534 Americas: +1 315 623 0293 Email: info@tbrc.info

Follow Us On: LinkedIn: https://in.linkedin.com/company/the-business-research-company Twitter: https://twitter.com/tbrc_info Facebook: https://www.facebook.com/TheBusinessResearchCompany YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ Blog: https://blog.tbrc.info/ Healthcare Blog: https://healthcareresearchreports.com/ Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

[amr-jayprakash]

The global tobacco market was valued at $183.1 billion in 2019 and is estimated to reach $262.8 billion by 2027, registering a CAGR of 6.7% from 2021 to 2027. Tobacco is a common name for the plant Nicotiana tabacum and, to a lesser extent, Aztec tobacco (Nicotiana Rustica). The cured leaf is used for smoking, chewing, snuffing, and nicotine extraction after maturation and processing in various ways. Other Nicotiana species, collectively known as flowering tobaccos, are grown as ornamentals. Tobacco consumption in any form stimulates brain functions, raises blood pressure, constricts peripheral blood vessels, and increases heart rate. At the same time, tobacco consumption in any form can pose health risks and affect a large population of passive smokers globally. Tobacco contains alkaloids that are highly addictive, making it difficult to quit. Despite consumer awareness of the health effects of tobacco use, the tobacco industry is gaining traction due to the addictive nature of the product.

[themarketinsights]

Tobacco and Hookah Market Growing Popularity and Emerging Trends |Fumari, Alchemist Tobacco, Social Smoke, Haze Tobacco

Advance Market Analytics published a new research publication on “Global Tobacco and Hookah Market Insights, to 2027” with 232 pages and enriched with self-explained Tables and charts in presentable format. In the study, you will find new evolving Trends, Drivers, Restraints, Opportunities generated by targeting market-associated stakeholders. The growth of the Tobacco and Hookah market was mainly driven by the increasing R&D spending across the world.

Major players profiled in the study are:

Al Fakher (United Arab Emirates), Fumari (United States), Japan Tobacco (Japan), Middle East Tobacco (United Arab Emirates), ShopStarBuzz (United States), Fantasia (United States), Social Smoke (United States), Alchemist Tobacco (United States), Al-Tawareg Tobacco (Jorden), Haze Tobacco (United States),

Get Exclusive PDF Sample Copy of This Research @ https://www.advancemarketanalytics.com/sample-report/67863-global-tobacco-and-hookah-market-1#utm_source=DigitalJournalVinay

Scope of the Report of Tobacco and Hookah

Hookah and tobacco are the substance used for addition. Tobacco is prepared from leaves of the tobacco plant by curing them. Hookah is instruments used for smoking flavored of tobacco. There are various flavors are available in hookahs such as mix flavor, herbal flavor, and fruit flavor. Flavored hookah does not contain nicotine and it is not addictive as compared to cigarettes. Advanced technologies have supported the tobacco and hookah industry in automating manufacturing procedures, in contrast to traditional manufacturing techniques that were labor dependent.

The Global Tobacco and Hookah Market segments and Market Data Break Down are illuminated below:

by Type (Fruit Flavor, Mixed Flavor, Herbal Flavor), Application (Hotels & Restaurants, Bars, Hookah Parlour), Distribution Channel (Offline Sales, Online Sales )

Market Drivers:

Increasing Online Retailing

Fast Development of E- Commerce Industry

Market Trend:

Attraction towards Different Flavors

Adoption of Innovative and New Product

What can be explored with the Tobacco and Hookah Market Study?

Gain Market Understanding

Identify Growth Opportunities

Analyze and Measure the Global Tobacco and Hookah Market by Identifying Investment across various Industry Verticals

Understand the Trends that will drive Future Changes in Tobacco and Hookah

Understand the Competitive Scenarios

Track Right Markets

Identify the Right Verticals

Region Included are: North America, Europe, Asia Pacific, Oceania, South America, Middle East & Africa

Country Level Break-Up: United States, Canada, Mexico, Brazil, Argentina, Colombia, Chile, South Africa, Nigeria, Tunisia, Morocco, Germany, United Kingdom (UK), the Netherlands, Spain, Italy, Belgium, Austria, Turkey, Russia, France, Poland, Israel, United Arab Emirates, Qatar, Saudi Arabia, China, Japan, Taiwan, South Korea, Singapore, India, Australia and New Zealand etc.

Have Any Questions Regarding Global Tobacco and Hookah Market Report, Ask Our Experts@ https://www.advancemarketanalytics.com/enquiry-before-buy/67863-global-tobacco-and-hookah-market-1#utm_source=DigitalJournalVinay

Strategic Points Covered in Table of Content of Global Tobacco and Hookah Market:

Chapter 1: Introduction, market driving force product Objective of Study and Research Scope the Tobacco and Hookah market

Chapter 2: Exclusive Summary – the basic information of the Tobacco and Hookah Market.

Chapter 3: Displaying the Market Dynamics- Drivers, Trends and Challenges & Opportunities of the Tobacco and Hookah

Chapter 4: Presenting the Tobacco and Hookah Market Factor Analysis, Porters Five Forces, Supply/Value Chain, PESTEL analysis, Market Entropy, Patent/Trademark Analysis.

Chapter 5: Displaying the by Type, End User and Region/Country 2016-2021

Chapter 6: Evaluating the leading manufacturers of the Tobacco and Hookah market which consists of its Competitive Landscape, Peer Group Analysis, BCG Matrix & Company Profile

Chapter 7: To evaluate the market by segments, by countries and by Manufacturers/Company with revenue share and sales by key countries in these various regions (2022-2027)

Chapter 8 & 9: Displaying the Appendix, Methodology and Data Source

Finally, Tobacco and Hookah Market is a valuable source of guidance for individuals and companies.

Read Detailed Index of full Research Study at @ https://www.advancemarketanalytics.com/buy-now?format=1&report=67863#utm_source=DigitalJournalVinay

Contact Us:

Craig Francis (PR & Marketing Manager)

AMA Research & Media LLP

Unit No. 429, Parsonage Road Edison, NJ

New Jersey USA – 08837

[rupalic]

Global Fungicides Market Forecast to 2029: Innovations in Seed and Soil Treatment

The fungicides market is a critical segment of the agricultural chemicals industry, playing a vital role in crop protection by controlling fungal diseases that can significantly impact crop yield and quality. Fungicides are chemical compounds or biological organisms used to kill or inhibit the growth of fungi and fungal spores. They are widely used in agriculture to protect crops such as cereals, grains, fruits, vegetables, and ornamental plants from various fungal diseases like blights, rusts, and mildews.

Fungicides Market Size

The global fungicides market has been experiencing steady growth due to rising demand for food security, increasing global population, and the need to improve agricultural productivity.

The global fungicides market is estimated at USD 23.9 billion in 2024 and is projected to reach USD 32.3 billion by 2029, at a CAGR of 6.2% during the forecast period.

Fungicides Market Growth Drivers

Growing Demand for High Crop Yield and Quality: Farmers are increasingly adopting fungicides to enhance crop yield and protect crops from diseases, ensuring high-quality output.

Rising Awareness of Food Security: With the global population continuing to grow, there is an increasing emphasis on maximizing crop output to ensure food security.

Know about the assumptions considered for the study

Technological Advancements in Fungicide Development: Innovations in fungicide formulations, such as bio-based fungicides and integrated pest management strategies, are driving market expansion.

Expansion of Organic Farming: The growing trend of organic farming has led to an increased demand for bio-fungicides, which are environmentally friendly and safer for use.

How North America Maintains a Strong Fungicides Market Share?

The fungicides market commands a significant share in North America due to the region's robust agricultural infrastructure and widespread adoption of advanced crop protection technologies. This region is characterized by diverse and extensive farming practices, creating a strong demand for effective fungicide solutions to combat a variety of fungal diseases and ensure high crop yields. Key agricultural zones such as the Rio Grande Valley in Texas and Mexico (known for citrus fruits), California's Central Valley (fruits and vegetables), the Gulf Coastal Plain (vegetables), and the Appalachian sandy valleys (cotton and tobacco) are vital contributors to this demand. Furthermore, North America is home to leading fungicide manufacturers and substantial investments in research and development, driving innovation and enhancing product availability. Supportive government regulations aimed at boosting agricultural productivity further strengthen the demand for fungicides, solidifying North America's leading position in the global fungicides industry.

The Rise of Bio-Fungicides: A Sustainable Future for Crop Protection

A significant opportunity in the global fungicides market lies in the rising demand for bio-fungicides, driven by increasing consumer awareness and regulatory mandates to adopt more sustainable farming practices. As environmental concerns and organic farming initiatives gain momentum, both farmers and regulatory bodies are seeking alternatives to traditional chemical fungicides. Bio-fungicides, derived from natural sources, offer an eco-friendly solution that aligns with the goals of organic and sustainable agriculture. These products help reduce the environmental impact of crop protection while catering to the growing market of health-conscious consumers who prefer foods produced with minimal synthetic inputs.

Global Fungicides Leaders: Bayer, BASF, and Corteva Drive Growth with New Technologies and Strategic Moves

Bayer AG, BASF SE, and Corteva are leading players in the global fungicides and crop protection markets, each bringing innovative solutions to address agricultural challenges. Bayer AG, a German multinational, operates across pharmaceuticals, consumer health, and crop science segments, with fungicides like Flint, Fox, Luna, Sonata, and Mikal under its agricultural portfolio. In July 2024, Bayer launched the Valpura fungicide in Brazil, featuring bixafen for effective and long-lasting disease control, enhancing crop yields for potatoes, tomatoes, grapes, and apples.

Make an Inquiry to Address your Specific Business Needs

BASF SE, another German giant, specializes in chemicals and crop protection products. In March 2024, BASF announced its investment in a new fermentation plant in Ludwigshafen to produce biological fungicides and seed treatments, slated to open in late 2025. Corteva, a U.S.-based agricultural firm spun off from DowDuPont, focuses on crop protection, seeds, and sustainable farming practices. In March 2023, Corteva acquired Stoller, a leading company in the biologicals sector, reinforcing its commitment to green and sustainable agricultural solutions. Together, these companies are driving innovation and sustainability in the global crop protection landscape.

Fungicides Industry Update: Recent Launches and Technological Advancements

In June 2024, BASF SE launched its new rice fungicide, Cevya (400g/L mefentrifluconazole), in China that features the active ingredient Revysol (mefentrifluconazole) for effective prevention and control of rice false smut.

In August 2023, Bayer AG invested USD 231.3 million to construct a new R&D facility at its Monheim site. This investment marked Germany's largest single financial commitment towards crop protection in the last four decades. The R&D facility was designed to accommodate approximately 200 employees. By implementing advanced safety measures, including early safety screens and Artificial Intelligence (AI), Bayer aimed to develop the next generation of safe and sustainable crop protection products. This will help develop new fungicide products.

In March 2023, Corteva acquired Stoller, one of the largest independent companies in the biologicals sector, headquartered in Houston, Texas. This acquisition will strengthen Corteva’s dedication to offering farmers environmentally friendly, sustainable solutions that align with advancing farming practices and demonstrate proven effectiveness.

[jayanthitbrc]

Global Liquid Oxygen Devices Market Analysis 2024: Size Forecast and Growth Prospects

The liquid oxygen devices global market report 2024from The Business Research Company provides comprehensive market statistics, including global market size, regional shares, competitor market share, detailed segments, trends, and opportunities. This report offers an in-depth analysis of current and future industry scenarios, delivering a complete perspective for thriving in the industrial automation software market.

Liquid Oxygen Devices Market, 2024report by The Business Research Company offers comprehensive insights into the current state of the market and highlights future growth opportunities.

Market Size - The liquid oxygen devices market size has grown strongly in recent years. It will grow from $5.65 billion in 2023 to $6.06 billion in 2024 at a compound annual growth rate (CAGR) of 7.2%. The growth in the historic period can be attributed to the rising incidence of respiratory disorders, the growing aging population, increased healthcare spending globally, the shift towards home-based care, favorable government initiatives and regulatory policies, and growing awareness and education.

The liquid oxygen devices market size is expected to see strong growth in the next few years. It will grow to $8.04 billion in 2028 at a compound annual growth rate (CAGR) of 7.3%. The growth in the forecast period can be attributed to the increasing preference for portable oxygen concentrators over traditional oxygen tanks, increasing healthcare infrastructure, expanding applications in non-medical settings, growing emphasis on home-based care and telemedicine, and increasing awareness of environmental sustainability. Major trends in the forecast period include miniaturization and portability of liquid oxygen devices to enhance mobility and convenience for users, integration of Internet of Things (IoT) technology and digital health platform, development of advanced battery technology, introduction of smart oxygen delivery systems, and development of customizable liquid oxygen devices.

Order your report now for swift delivery @ https://www.thebusinessresearchcompany.com/report/liquid-oxygen-devices-global-market-report

Scope Of Liquid Oxygen Devices MarketThe Business Research Company's reports encompass a wide range of information, including:

1. Market Size (Historic and Forecast): Analysis of the market's historical performance and projections for future growth.

2. Drivers: Examination of the key factors propelling market growth.

3. Trends: Identification of emerging trends and patterns shaping the market landscape.

4. Key Segments: Breakdown of the market into its primary segments and their respective performance.

5. Focus Regions and Geographies: Insight into the most critical regions and geographical areas influencing the market.

6. Macro Economic Factors: Assessment of broader economic elements impacting the market.

Liquid Oxygen Devices Market Overview

Market Drivers -The increasing incidence of respiratory disorders is expected to propel the growth of the liquid oxygen device market going forward. Respiratory disorders refer to a range of medical conditions affecting the respiratory system, which includes the lungs, airways, and other structures involved in breathing. The increasing number of respiratory disorders are caused by air pollution, tobacco smoke exposure, occupational hazards, genetic predisposition, and lifestyle choices. Liquid oxygen devices provide crucial respiratory support for individuals with respiratory disorders, facilitating easier breathing and improving quality of life, while also offering healthcare providers a reliable means to administer oxygen therapy and monitor patients' respiratory health. For instance, in 2021, according to the National Centre for Environmental Health, a US-based health agency, overall, about 25 million (7.7% of the U.S. population) had asthma in 2021, an increase from 20.3 million, or 7.4% compared to the previous decade. Additionally, in June 2023, according to the American Lungs Association, a US-based health agency, about 15.6 million adults (6.4 percent) reported ever being diagnosed with COPD in 2021. Therefore, an increasing incidence of respiratory disorders is driving the liquid oxygen device market.

Market Trends - Major companies operating in the liquid oxygen devices market are focusing on developing advanced solutions, such as incorporating innovative cooling designs to keep the device cool during operation, ensuring optimal performance and reliability over time. The twin-blower cooling design for liquid oxygen devices involves a system where air is compressed, cooled, and separated into oxygen and nitrogen. For instance, in April 2023, OxyGo HQ Florida LLC, a US-based manufacturer of portable oxygen concentrators, launched the OxyHome 5L Stationary Concentrator. This new device is designed to provide a continuous flow of oxygen up to 5 liters per minute for home use. It has a modern design and a small footprint to fit comfortably in any home environment. The key feature highlighted is its twin-blower cooling design, ensuring optimal and reliable performance over time.

The liquid oxygen devices market covered in this report is segmented –

1) By Tank Type: Vertical Storage Tanks, Horizontal Storage Tanks 2) By Distribution Channel: Direct Sales, Indirect Sales 3) By End-User: Hospitals, Outpatient Facilities, Home Care, Other End-Users

Get an inside scoop of the liquid oxygen devices market, Request now for Sample Report @ https://www.thebusinessresearchcompany.com/sample.aspx?id=15601&type=smp

Regional Insights - North America was the largest region in the liquid oxygen devices market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the liquid oxygen devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Key Companies - Major companies operating in the liquid oxygen devices market are Air Liquide S.A., Linde plc, Teijin Limited, NTK Oxygen Electronics Co. Ltd., Chart Industries Inc., Invacare Corporation, Cryoquip LLC, ErgoMed Inc., CAIRE Inc., Taylor-Wharton International LLC, DeVilbiss Healthcare, VRV S.p.A., Eleet Cryogenics Inc., FIBA Technologies Inc., Inova Labs, OxyGo LLC, Cryofab Inc., O2 CONCEPTS LLC, PCI Gases, HVM Medical Inc., Oxygen Plus Inc., Oxygen Solutions Inc., Besco Medical Co. Ltd., Nidek Medical, INOXCVA

Table of Contents 1. Executive Summary2. Liquid Oxygen Devices Market Report Structure3. Liquid Oxygen Devices Market Trends And Strategies4. Liquid Oxygen Devices Market – Macro Economic Scenario5. Liquid Oxygen Devices Market Size And Growth…..27. Liquid Oxygen Devices Market Competitor Landscape And Company Profiles28. Key Mergers And Acquisitions 29. Future Outlook and Potential Analysis 30. Appendix

Contact Us: The Business Research Company Europe: +44 207 1930 708 Asia: +91 88972 63534 Americas: +1 315 623 0293 Email: info@tbrc.info

Follow Us On: LinkedIn: https://in.linkedin.com/company/the-business-research-company Twitter: https://twitter.com/tbrc_info Facebook: https://www.facebook.com/TheBusinessResearchCompany YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ Blog: https://blog.tbrc.info/ Healthcare Blog: https://healthcareresearchreports.com/ Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model